About Previpharma India Private Limited
Data last updated:
Previpharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 10 October 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U46497TS2023PTC177885.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satish Kumar Devarapu and Gadda Sai Vijay Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.61 Cr, a growth of 99% compared to the previous year. For the same year it recorded a net profit of ₹21.12 Lakh (net margin 13.1%) and EBITDA of ₹30.26 Lakh (EBITDA margin 18.8%).
The company is associated with 1 brand: PreviPharma.
For more details, the company can be reached via its website previpharma.com.
Company details
Contact details
Previpharma India Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressAic – Ccmb 3rd Floor Medical Biotechnology Complex, Ccmb Annex 2 Genpact Road Ida Uppal, Hyderabad, Telangana, India – 500039
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Previpharma India operates one associated brand: PreviPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides research and development services for plasma fractionation and industry partnerships. | previpharma.com |
Business activity
The main business activity of Previpharma India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Previpharma India Private Limited, buy the company report.
Financials of Previpharma India Private Limited
FY 2025 filings availablePrevipharma India Private Limited reported revenue of ₹1.61 Cr (up 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 99% in the latest year. EBITDA rose 139% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹30.26 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹21.12 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 18.8% | |
| Net Profit Margin | 13.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Previpharma India Private Limited, buy the company report.
Board of directors of Previpharma India Private Limited
Previpharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kumar Devarapu | Director | 28 Dec 2023 | 2 Years 9 Months | Current |
| Gadda Sai Vijay Kumar | Director | 10 Oct 2023 | 3 Years 0 Months | Current |
| Marc Mazur Michael | Director | 10 Oct 2023 | 3 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Previpharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Previpharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Previpharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Previpharma India Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Satish Kumar Devarapu was appointed as Director on 28 Dec 2023.
Frequently asked questions
Previpharma India is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 10 October 2023 (3+ years old) and is registered under CIN U46497TS2023PTC177885.
Previpharma India has 3 current directors:
- Satish Kumar Devarapu - Director
- Gadda Sai Vijay Kumar - Director
- Marc Mazur Michael - Director
The latest financial statements of Previpharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Previpharma India is U46497TS2023PTC177885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Previpharma India was incorporated on 10 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Satish Kumar Devarapu was appointed as Director on 28 Dec 2023. Gadda Sai Vijay Kumar was appointed as Director on 10 Oct 2023. Marc Mazur Michael was appointed as Director on 10 Oct 2023.
Previpharma India can be reached through the website previpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Previpharma India is at Aic – Ccmb 3rd Floor Medical Biotechnology Complex, Ccmb Annex 2 Genpact Road Ida Uppal, Hyderabad, Telangana, India – 500039.
Previpharma India has 1 associated brand: Previpharma.
Previpharma India is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.